Annual report pursuant to Section 13 and 15(d)

Investments, Non-Marketable Cost Method Investments (Details)

v3.22.4
Investments, Non-Marketable Cost Method Investments (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 25, 2021
Dec. 26, 2020
Gain (Loss) on Securities [Line Items]      
Non-marketable equity securities $ 10 $ 16  
Impairments 190 154 $ 303
Cumulative impairment for equity securities without readily determinable fair value 955 916  
Upward observable price adjustments for equity securities without readily determinable fair value 1,400 1,100  
Cost-method Investments [Member]      
Gain (Loss) on Securities [Line Items]      
Impairments $ 190 $ 154 $ 290